Minimally Invasive Open Excisional Hemorrhoidectomy Compared to Conventional Open Excisional Hemorrhoidectomy: a Clinical Trial

Launched by HOSPITAL SON LLATZER · Jan 2, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new method for treating hemorrhoids called minimally invasive open excisional hemorrhoidectomy. The goal is to see if this approach can reduce pain after surgery while still providing the same benefits as the traditional method. The researchers want to find out if patients experience less discomfort and have a smoother recovery with this newer technique.

To be eligible for the trial, participants need to be over 18 years old and have grade III hemorrhoids, which means their hemorrhoids are severe enough to require surgery. People with certain conditions, like recent hemorrhoid issues, previous surgeries for hemorrhoids, or other specific health problems, won’t be able to join the study. If you participate, you can expect to receive careful monitoring during and after the surgery to help assess your pain levels and recovery. The trial is currently not open for recruitment, but it may be an option for those looking for treatment in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age older than 18 years.
• • Hemorrhoids grade III.
• • Surgical indication for hemorrhoidal disease.
• Exclusion Criteria:
• • Acute hemorrhoidal disease.
• • Previous hemorrhoidal surgery.
• • Concomitant anal fissure.
• • Concomitant anal fistulae.
• • Concomitant rectal prolapse.
• • Concomitant inflamatory bowel disease or anal cancer.
• • Language impairment.